Nonoperating Income (Expense) in USD of Xenetic Biosciences, Inc. from Q2 2013 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Xenetic Biosciences, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q2 2013 to Q3 2025.
  • Xenetic Biosciences, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was $34.8K, a 44.6% decline year-over-year.
  • Xenetic Biosciences, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $154K, a 45.6% decline year-over-year.
  • Xenetic Biosciences, Inc. annual Nonoperating Income (Expense) for 2024 was $244K, a 35.9% decline from 2023.
  • Xenetic Biosciences, Inc. annual Nonoperating Income (Expense) for 2023 was $381K, a 130% increase from 2022.
  • Xenetic Biosciences, Inc. annual Nonoperating Income (Expense) for 2022 was $166K, a 63% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Xenetic Biosciences, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $154K $34.8K -$28K -44.6% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $182K $35.7K -$27.7K -43.7% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 $210K $39.3K -$34K -46.4% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 $244K $44.6K -$39.5K -47% 01 Oct 2024 31 Dec 2024 10-K 18 Mar 2025
Q3 2024 $284K $62.8K -$28.3K -31.1% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $312K $63.4K -$83.8K -56.9% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 $396K $73.3K +$14.7K +25% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 $381K $84.2K +$3.37K +4.17% 01 Oct 2023 31 Dec 2023 10-K 18 Mar 2025
Q3 2023 $378K $91.1K +$47.4K +108% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $330K $147K +$132K +889% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $198K $58.6K +$32.5K +125% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $166K $80.8K +$48.4K +150% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 $117K $43.8K +$18.6K +74.2% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $98.5K $14.9K -$6.08K -29% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $105K $26.1K +$2.96K +12.8% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $102K $32.3K +$12.4K +61.8% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 $89.2K $25.1K -$393 -1.54% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $89.6K $21K -$7.84K -27.2% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $97.5K $23.1K -$28.2K -54.9% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $126K $20K -$44.6K -69.1% 01 Oct 2020 31 Dec 2020 10-K 22 Mar 2022
Q3 2020 $170K $25.5K -$20.9K -45% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $191K $28.8K +$27.9K +3109% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $163K $51.4K +$51.4K 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q4 2019 $112K $64.6K +$64.3K +22729% 01 Oct 2019 31 Dec 2019 10-K 16 Mar 2021
Q3 2019 $47.5K $46.4K +$44K +1873% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $3.44K $898 +$33.5K 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 -$30.1K -$95* -$5.92K 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$24.1K $283 -$14.2K -98% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2020
Q3 2018 -$9.91K $2.35K +$17.8K 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$27.7K -$32.6K -$17.1K -110% 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$10.6K $5.83K +$15.8K 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019
Q4 2017 -$26.4K $14.5K +$341K 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 -$368K -$15.4K +$205K +93% 01 Jul 2017 30 Sep 2017 10-Q 09 Nov 2018
Q2 2017 -$573K -$15.5K +$4.49M +99.7% 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018
Q1 2017 -$5.07M -$9.94K +$1.71M +99.4% 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018
Q4 2016 -$6.78M -$327K +$609K +65.1% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2018
Q3 2016 -$7.38M -$220K +$1.3M +85.5% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$8.69M -$4.51M -$4.74M -2027% 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017
Q1 2016 -$3.94M -$1.72M -$1.26M -273% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$2.69M -$936K -$850K -993% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$1.84M -$1.52M -$1.45M -1962% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$386K $234K +$353K 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$739K -$461K +$643K +58.2% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$1.38M -$85.6K 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$73.9K +$125K +62.9% 01 Jul 2014 30 Sep 2014 10-Q 16 Nov 2015
Q2 2014 -$119K -$213K -226% 01 Apr 2014 30 Jun 2014 10-Q 19 Aug 2015
Q1 2014 -$1.1M 01 Jan 2014 31 Mar 2014 10-Q 20 May 2015
Q3 2013 -$199K 01 Jul 2013 30 Sep 2013 10-Q 14 Nov 2014
Q2 2013 $94.1K 01 Apr 2013 30 Jun 2013 10-Q 14 Aug 2014

Xenetic Biosciences, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $244K -$137K -35.9% 01 Jan 2024 31 Dec 2024 10-K 18 Mar 2025
2023 $381K +$216K +130% 01 Jan 2023 31 Dec 2023 10-K 18 Mar 2025
2022 $166K +$64K +63% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $102K -$24.1K -19.2% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 $126K +$13.9K +12.4% 01 Jan 2020 31 Dec 2020 10-K 22 Mar 2022
2019 $112K +$136K 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2021
2018 -$24.1K +$2.24K +8.49% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2020
2017 -$26.4K +$6.75M +99.6% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019
2016 -$6.78M -$4.09M -152% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2018
2015 -$2.69M -$1.3M -94.3% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$1.38M -$1.35M -4226% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$32K 01 Jan 2013 31 Dec 2013 10-K 15 Apr 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.